About Changsha Chenchen Pharmaceutical Technology
Changsha Chenchen Pharmaceutical Technology is a company based in Changsha (China) founded in 2020. Changsha Chenchen Pharmaceutical Technology has raised $13.97 million across 1 funding round from investors including Yuansheng Capital, Sanze Venture Capital and Jinyu Maowu. Changsha Chenchen Pharmaceutical Technology operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
- Headquarter Changsha, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.97 M (USD)
in 1 rounds
-
Latest Funding Round
$13.97 M (USD), Series A
Dec 14, 2023
-
Investors
Yuansheng Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Changsha Chenchen Pharmaceutical Technology
Changsha Chenchen Pharmaceutical Technology has successfully raised a total of $13.97M through 1 strategic funding round. The most recent funding activity was a Series A round of $13.97 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Changsha Chenchen Pharmaceutical Technology
Changsha Chenchen Pharmaceutical Technology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Yuansheng Capital, Sanze Venture Capital and Jinyu Maowu.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Changsha Chenchen Pharmaceutical Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Changsha Chenchen Pharmaceutical Technology
Investment portfolio details for Changsha Chenchen Pharmaceutical Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Changsha Chenchen Pharmaceutical Technology
Detailed financials for Changsha Chenchen Pharmaceutical Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Changsha Chenchen Pharmaceutical Technology Comparisons
Peer comparison for Changsha Chenchen Pharmaceutical Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Changsha Chenchen Pharmaceutical Technology
Changsha Chenchen Pharmaceutical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and Aparna Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and intermediates are manufactured by Viyash as a CDMO.
|
|
| Locked | Locked | Locked |
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| Locked | Locked | Locked |
Advanced API intermediates are manufactured for pharmaceutical use.
|
|
| Locked | Locked | Locked |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| Locked | Locked | Locked |
Manufactures and exports pharmaceutical intermediates for global markets.
|
Detailed competitors of Changsha Chenchen Pharmaceutical Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Changsha Chenchen Pharmaceutical Technology
Complete news archive for Changsha Chenchen Pharmaceutical Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Changsha Chenchen Pharmaceutical Technology
Changsha Chenchen Pharmaceutical Technology was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Changsha Chenchen Pharmaceutical Technology is headquartered in Changsha, China. It is registered at Changsha, Hunan, China.
Changsha Chenchen Pharmaceutical Technology is a funded company, having raised a total of $13.97M across 1 funding round to date.
Changsha Chenchen Pharmaceutical Technology Co., Ltd. was founded in 2020 and is based in Changsha, China. Operations focus on chemical impurity research, drug impurity separation, and identification within the pharmaceutical technology sector. A team of over 100 professionals is employed, with expertise in chemical synthesis, separation, analysis, biotechnology, and data algorithms. Biopharmaceutical services are also provided to support these activities.
Changsha Chenchen Pharmaceutical Technology's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Changsha Chenchen Pharmaceutical Technology has 3 investors. Key investors include Yuansheng Capital, Sanze Venture Capital, and Jinyu Maowu.